Skip to main content
. 2017 Aug 1;8(45):79825–79834. doi: 10.18632/oncotarget.19781

A) ATA risk classification.

Before SPECT/CT
low intermediate high TOTAL
After SPECT/CT Low 124 83 5 212
Intermediate 11 70 7 88
high 3 6 14 23
TOTAL 138 159 26 323